Stay updated on PROMO: Pembrolizumab in Osteosarcoma Clinical Trial
Sign up to get notified when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.

Latest updates to the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page
- Check2 days agoChange DetectedRecruitment status was updated to indicate no longer looking for participants. New help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) were added, a label formatting change for Intervention/Treatment was made, and the site revision tag was updated to v3.6.0.SummaryDifference0.6%

- Check9 days agoChange DetectedThe revision tag at the bottom of the page updated from v3.5.4 to v3.5.5, indicating a minor update to the study record page. This change represents a small version bump rather than a modification to the study data or content.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a minor metadata update to the page. This does not reflect a change in core content or functionality.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a site/build metadata change rather than an alteration to the clinical trial content.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Revision: v3.5.2 and deleted Revision: v3.5.0.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision label updated to v3.5.0, replacing the previous v3.4.3 label.SummaryDifference0.1%

Stay in the know with updates to PROMO: Pembrolizumab in Osteosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.